- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06094361
"IONTOPHORESIS vs. PHONOPHORESIS" for Treatment of Subacromial Impingement Syndrome
"IONTOPHORESIS vs. PHONOPHORESIS": WHICH IS A BEST WAY TO TREAT SUBACROMIAL IMPINGEMENT SYNDROME? A RANDOMIZED STUDY
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Randomization: Forty-seven patients were assessed, and 43 completed the study in this randomized trial. The participants were divided into two groups (Iontophoresis:22 and Phonophoresis:21) using the online randomization software (www.randomizer.org). All patients gave written informed consent after being verbally informed about the study.
Assessment Period: Assessments were conducted twice, at the start and after completion of the 10-session treatment program.
Session Period: All treatment programs were delivered five days per week for two weeks. The total number of sessions was ten.
Analysis: The statistical analysis was performed using version 21 of the Statistical Package for the Social Sciences (SPSS).To verify normal distribution, the Shapiro-Wilk test and histogram curves were utilized. Descriptive statistics for parametric variables included mean, standard deviation, and percentage. Since the data exhibited normal distribution, independent sample T-tests were used for group comparison while paired sample T-tests were used to detect changes within the group. The significance level of p<0.05 was deemed acceptable for all analyses. For variables with nominal assessments, data were analyzed utilizing Yates Continuity Correction and Fisher's exact chi-square test.
The post hoc power of the study was calculated using Gpower 3.1.9.1 software. The resting VAS scores was taken as reference. In this context, Cohen's effect size was calculated as 1.00. When the alpha error was accepted as 5%, and effect size was 1.00, the post hoc power was found to be 94.27%.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey, 34083
- Marmara University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients diagnosed with Stage I-II SIS
- The ages between 18 and 65 years
Exclusion Criteria:
- Having underwent shoulder surgery,
- Participated in a shoulder-related treatment program within the previous six months,
- Failed to adhere to the treatment program by 70% or more
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: IONTOPHORESIS
The group that received 75 mg diclofenac sodium with Chattanooga Physio device.
|
Iontophoresis was applied with a Chattanooga Physio (DJO Global, Herentals, Belgium) brand device.
The galvanic current mode was selected for the intervention.
Intervention area was cleaned to prevent irritation and active electrode pad (cathode-5 cm2) was immersed in 75 mg diclofenac sodium solution.
The current intensity of the application for 10 minutes was 0.1-0.2
mA/cm2.
All groups received a treatment program consisting of hot pack, Transcutaneous Electrical Nerve Stimulation and Shoulder girdle exercises for 30 minutes.
|
|
Experimental: PHONOPHORESIS
It is a treatment performed by applying 75 mg of 1% diclofenac sodium gel to the intervention area with the Chattanooga ultrasound device.
|
All groups received a treatment program consisting of hot pack, Transcutaneous Electrical Nerve Stimulation and Shoulder girdle exercises for 30 minutes.
Phonophoresis was performed with a Chattanooga brand ultrasound device (Chattanooga, Intelect Legend Ultrasound, TN, USA).
75 mg gel containing 1% diclofenac sodium was applied to the shoulder area.
The ultrasound was conducted continuously for 6 minutes with frequency of 1 MHz and an intensity of 1.5 watts/cm2.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analog Scale
Time Frame: At the baseline
|
This scale assess the pain of the patients.
The scale is scored from 0-10, with 0 indicating no pain and 10 indicating intolerable pain.
|
At the baseline
|
|
Visual Analog Scale
Time Frame: Immediately after 10 physiotherapy sessions on consecutive days
|
This scale assess the pain of the patients.
The scale is scored from 0-10, with 0 indicating no pain and 10 indicating intolerable pain.
|
Immediately after 10 physiotherapy sessions on consecutive days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sociodemographic Data Form
Time Frame: At the baseline
|
It is a form containing the descriptive characteristics of the patients.
|
At the baseline
|
|
Range of Motion
Time Frame: At the baseline
|
The angular values of flexion, extension, abduction, internal and external rotation performed actively by the patients were examined with a universal goniometer.
|
At the baseline
|
|
Range of Motion
Time Frame: Immediately after 10 physiotherapy sessions on consecutive days
|
The angular values of flexion, extension, abduction, internal and external rotation performed actively by the patients were examined with a universal goniometer.
|
Immediately after 10 physiotherapy sessions on consecutive days
|
|
Shoulder Disability Questionnaire
Time Frame: At the baseline
|
This scale is a sixteen-item scale that assesses disability in individuals with shoulder complaints
|
At the baseline
|
|
Shoulder Disability Questionnaire
Time Frame: Immediately after 10 physiotherapy sessions on consecutive days
|
This scale is a sixteen-item scale that assesses disability in individuals with shoulder complaints
|
Immediately after 10 physiotherapy sessions on consecutive days
|
|
Quick-Disabilities of the Arm, Shoulder and Hand Questionnaire
Time Frame: At the baseline
|
In the scale, the functional status of individuals with shoulder pathology is questioned during their daily activities, and it is an assessment form filled by the patients themselves.
|
At the baseline
|
|
Quick-Disabilities of the Arm, Shoulder and Hand Questionnaire
Time Frame: Immediately after 10 physiotherapy sessions on consecutive days
|
In the scale, the functional status of individuals with shoulder pathology is questioned during their daily activities, and it is an assessment form filled by the patients themselves.
|
Immediately after 10 physiotherapy sessions on consecutive days
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 02.06.2015.284
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.